World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
VRTXVertex Pharmaceuticals | $114.06bn | 28.67 | n/a |
REGNRegeneron Pharmaceuticals | $109.52bn | 28.34 | n/a |
MRNAModerna | $55.07bn | n/a | n/a |
SGENSeagen | $43.15bn | n/a | n/a |
IQVIqvia Holdings | $41.79bn | 29.78 | n/a |
LONNLonza AG | CH₣36.62bn | 35.26 | 0.79% |
068270Celltrion | KR₩38tn | 68.4 | 0.27% |
ICLRIcon | $26.28bn | 35.15 | n/a |
BNTXBioNTech SE | $21.89bn | 168.97 | n/a |
ARGXargenx SE | €19.60bn | n/a | n/a |
GMABGenmab A/S | DKK130.43bn | 24.18 | n/a |
ALNYAlnylam Pharmaceuticals | $18.93bn | n/a | n/a |
NBIXNeurocrine Biosciences | $14.14bn | 38.23 | n/a |
TECHBIO-TECHNE | $13.03bn | 61.55 | 0.39% |
KRTXKaruna Therapeutics | $12.58bn | n/a | n/a |
MEDPMedpace Holdings | $12.29bn | 40.42 | n/a |
UTHRUnited Therapeutics | $12.21bn | 12.99 | n/a |
SRPTSarepta Therapeutics | $12.20bn | n/a | n/a |
CRLCharles River Laboratories International | $11.41bn | 23.72 | n/a |
QGENQiagen NV | $9.99bn | 27.02 | n/a |